Miranda

mgreenberg@dcat.org

LATEST

From the DCAT Alliance for Industry Women Committee: Webinar Recap: How to Apply Resilience to Your Finances
By

By
The DCAT Alliance for Industry Women Committee hosted a webinar earlier this month (May 2022), How to Money: Your Ultimate Guide to the Basics of Finance, featuring Jean Chatzky, the…

Don’t Miss the DCAT Alliance for Industry Women Committee’s Popular Interview Series Highlighting Women Leaders in Pharma
By

By
Want to gain the valuable perspectives from industry leaders on how they built their careers and what they see as most important for professional development? The DCAT Alliance for Industry…

Supplier News: Lonza, Catalent, AGC Biologics & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, Catalent, AGC Biologics, Cellipont Bioservices, ApiJect Systems, Societal CDMO, NJII, Schott, BD, and Gerresheimer. Highlights below. Biologics Manufacturing* Lonza, Kodiak Sciences…

Mfg News: Novartis, BMS, Vertex, Gilead, UCB & More
By

By
A roundup of manufacturing news from Novartis, Bristol-Myers Squibb, Vertex Pharmaceuticals, Gilead Sciences, and UCB. Highlights below. * Novartis To Sell UK API Mfg Facility* Korean Conglomerate Lotte To Buy…

FDA Launches Program To Facilitate Rare Disease Drug Development
By

By
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has launched a new program, the Accelerating Rare disease Cures (ARC) Program, to facilitate the development…

COVID News: Pfizer, AstraZeneca, Lilly, J&J, & More
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Pfizer, AstraZeneca, Lilly, J&J, GSK, and Novavax. Highlights below. Manufacturing and supply of COVID-19 vaccines and drugs* Pfizer, BioNTech Amend EU COVID-19…

Global Briefs: Bausch Health, ADC Therapeutics, Viatris & More
By

By
A roundup of news from Bausch Health, ADC Therapeutics, Viatris, Biocon Biologics, Emergent BioSolutions, Procaps Group, and Grupo Somar. Highlights below. * Bausch Health Names New CEO; Completes Spin-off of…

5 MINUTES WITH: Jim Fries, CEO, Rx-360
By

By
DCAT Value Chain Insights’ “5 Minutes With,” part of the DCAT Member Company Community section, features interviews with business and industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain.…

Pfizer To Acquire Biohaven Pharmaceuticals for $11.6 Bn
By

By
Pfizer has agreed to acquire Biohaven Pharmaceuticals, a bio/pharmaceutical company with lead assets for treating migraines, for approximately $11.6 billion. The pending acquisition follows the completion of a $1.24-billion licensing…

J&J Names CEO Designate of Planned Consumer Health Spin-off
By

By
Johnson & Johnson (J&J) has named Thibaut Mongon, Executive Vice President and Worldwide Chairman of Consumer Health at J&J, as CEO Designate of J&J’s to-be-spun-off, new Consumer Health company. J&J…